GlassScriptPhysician profile
Rajesh U Dhairyawan
NPI 1497758692
$8,644.12
in general payments reported to CMS, 2019-2025
30 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,794 · 2020: $1,150 · 2021: $2,168 · 2022: $874 · 2023: $1,055 · 2024: $997 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,657.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,516.12 | 2020-2021 | |
| Abbott Laboratories | $1,209.24 | 2019-2024 | Coroflow, Aveir |
| Amgen INC. | $992.23 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $702.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $617.08 | 2019-2025 | Camzyos, Eliquis |
| Zoll Circulation INC | $577.60 | 2021-2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Boston Scientific Corporation | $409.83 | 2019-2025 | Watchman Flx, General - Therapies |
| Kestra Medical Technology Services, INC. | $283.58 | 2022-2024 | Assure Wcd |
| Amarin Pharma, INC. | $267.63 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $231.88 | 2019-2025 | Farxiga |
| Impulse Dynamics (USA) INC. | $225.67 | 2022-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $193.02 | 2019 | |
| Pfizer INC. | $191.48 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $183.71 | 2024 | Inpefa |
| Atricure, INC. | $152.68 | 2022-2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $148.46 | 2024 | |
| Shockwave Medical, INC | $147.12 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $132.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $123.22 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $55.32 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $54.88 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $51.27 | 2019-2022 | |
| Terumo Medical Corporation | $29.86 | 2022 | |
| Esperion Therapeutics, INC. | $25.00 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $23.60 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $22.34 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $21.93 | 2025 | Shingrix, Arexvy |
| Philips North America LLC | $21.86 | 2023 | |
| Scpharmaceuticals INC. | $19.43 | 2023 | |
| Medicure Pharma INC. | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Dhairyawan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.